Response to botulinum toxin may predict response to peroral pyloromyotomy in patients with gastroparesis
Endoscopy · 01.06.2023 · 55 (06) · 508-514
DOI: 10.1055/a-1986-4292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2023. Verfasst von Vaibhav Wadhwa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Interventional Gastroenterology, University of Texas Health Science, Houston, Texas, United States. Hauptthemen laut MEDLINE: Gastroparesis, Pyloromyotomy, Botulinum Toxins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
Patients with gastroparesis who have undergone prior intrapyloric botulinum toxin injection (BTI) may seek an opinion regarding peroral pyloromyotomy (POP). There are only two small reports assessing the role of BTI as a predictor for successful treatment with POP.
Methods
We performed a retrospective cohort study to assess whether symptomatic improvement after BTI predicts a response to POP. We included 119 patients who had undergone both BTI and POP at Cleveland Clinic Ohio or Cleveland Clinic Florida from January 2016 to September 2019.
Results
65.5 % of patients had symptomatic improvement after BTI. Gastroparesis Cardinal Symptom Index (GCSI) scores were available for 74 patients, with 64 % achieving a response to POP, defined as a decrease in mean GCSI ≥ 1. In multivariable analysis, response to BTI (odds ratio [OR] 7.7 [95 %CI 2.2–26.1]) and higher pre-POP GCSI score (OR 2.3 [95 %CI 1.2–4.6]) were independent predictors of response to POP.
Conclusions
Clinical improvement after BTI is a predictor of response to POP in patients with gastroparesis. This information may aid in improving patient selection for POP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Interventional Gastroenterology, University of Texas Health Science, Houston, Texas, United States.
- Department of Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, Florida, United States.
- Department of Gastroenterology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States.
- Department of Clinical Research, Cleveland Clinic Florida, Weston, Florida, United States.
- Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio, United States.
ORCID-Profile: Adalberto Gonzalez
Zitieren
APA
Wadhwa, V., Gonzalez, A., Azar, F., Singh, H., Gupta, K., Liang, H., Schneider, A., Ponsky, J., Erim, T., Rodriguez, J., & Castro, F. J. (2023). Response to botulinum toxin may predict response to peroral pyloromyotomy in patients with gastroparesis. Endoscopy, 55(06), 508-514. https://doi.org/10.1055/a-1986-4292
Vancouver
Wadhwa V, Gonzalez A, Azar F, Singh H, Gupta K, Liang H, et al. Response to botulinum toxin may predict response to peroral pyloromyotomy in patients with gastroparesis. Endoscopy. 2023;55(06):508-514. doi:10.1055/a-1986-4292
BibTeX
@article{Wadhwa2023,
author = {Wadhwa, Vaibhav and Gonzalez, Adalberto and Azar, Francisco and Singh, Harjinder and Gupta, Kapil and Liang, Hong and Schneider, Alison and Ponsky, Jeffery and Erim, Tolga and Rodriguez, John and Castro, Fernando J},
title = {Response to botulinum toxin may predict response to peroral pyloromyotomy in patients with gastroparesis},
journal = {Endoscopy},
year = {2023},
volume = {55},
number = {06},
pages = {508--514},
doi = {10.1055/a-1986-4292}
}
EUVIMED